Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Han-yu Luo"'
Autor:
Han-yu Luo, Ling-ling Xie, Si-qi Hong, Xiu-juan Li, Mei Li, Yue Hu, Jian-nan Ma, Peng Wu, Min Zhong, Min Cheng, Ting-song Li, Li Jiang
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2021)
Objectives: To study the genetic and clinical characteristics of Chinese children with pathogenic proline-rich transmembrane protein 2 (PRRT2) gene-associated disorders.Methods: Targeted next generation sequencing (NGS) was used to identify pathogeni
Externí odkaz:
https://doaj.org/article/f801b295bd124b058319f54858230261
Autor:
Feng-Di Qin, Han-Yu Luo, Zheng-Zhong He, Ke-Jun Lu, Chuan-Gao Wang, Meng-Meng Wu, Zhong-Kai Fan, Jian Shan
Publikováno v:
Nuclear Science and Techniques. 34
Publikováno v:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 92
Guillain-Barré syndrome (GBS) is the leading cause of pediatric acute flaccid paralysis. This study aimed to summarize the clinical features of children with GBS and to explore factors associated with the severity of weakness. One hundred and twenty
Publikováno v:
MusclenerveREFERENCES. 62(2)
Background We assessed clinical predictors of mechanical ventilation in children with Guillain-Barre syndrome (GBS) to help identify patients who require mechanical ventilation. Methods We retrospectively collected the clinical, laboratory, and elect
Autor:
Xiao-Yu, Teng, Zhong-Zhen, Guan, Zhi-Wen, Yao, Dong-Geng, Liu, Ning-Ning, Zhou, Han-Yu, Luo, Michael, Hawkins, Patrick, Soon-Shiong
Publikováno v:
Ai zheng = Aizheng = Chinese journal of cancer. 23
Capxol is a Cremophor-free,protein stabilized, nanoparticle formulation of paclitaxel. This phase I study was designed to evaluate the tolerability/safety, toxicity profile, and maximum tolerated dose (MTD) of Capxol administered intravenously in Chi